Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Gregory C. Flaker"'
Publikováno v:
Antioxidants, Vol 12, Iss 12, p 2073 (2023)
Atherosclerosis remains a leading cause of cardiovascular diseases. Although the mechanism for atherosclerosis is complex and has not been fully understood, inflammation and oxidative stress play a critical role in the development and progression of
Externí odkaz:
https://doaj.org/article/790234a359644dacbd5d69fdff9c345c
Autor:
Qiang Zhu, Xuanyou Liu, Qingyi Zhu, Zehao Liu, Chunlin Yang, Hao Wu, Linfang Zhang, Xiujuan Xia, Meifang Wang, Hong Hao, Yuqi Cui, Guangsen Zhang, Michael A. Hill, Gregory C. Flaker, Shenghua Zhou, Zhenguo Liu
Publikováno v:
Antioxidants, Vol 11, Iss 6, p 1097 (2022)
Critical limb ischemia (CLI) is a severe complication of diabetes mellitus that occurs without effective therapy. Excessive reactive oxygen species (ROS) production and oxidative stress play critical roles in the development of diabetic cardiovascula
Externí odkaz:
https://doaj.org/article/f70112c9ce0743eda78bef16b9cffabf
Autor:
Xiujuan Xia, Linfang Zhang, Jingshu Chi, Huan Li, Xiaoming Liu, Tingzi Hu, Rong Li, Yinjie Guo, Xue Zhang, Hui Wang, Jin Cai, Yixi Li, Da Liu, Yuqi Cui, Xilong Zheng, Gregory C. Flaker, Duanfang Liao, Hong Hao, Zhenguo Liu, Canxia Xu
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 6 (2020)
Background Epidemiological studies have suggested an association between Helicobacter pylori (H pylori) infection and atherosclerosis through undefined mechanisms. Endothelial dysfunction is critical to the development of atherosclerosis and related
Externí odkaz:
https://doaj.org/article/e97eb332db9b4516b9c063e85702fc69
Autor:
Qingyi Zhu, Yichao Xiao, Meng Jiang, Xuanyou Liu, Yuqi Cui, Hong Hao, Gregory C. Flaker, Qiming Liu, Shenghua Zhou, Zhenguo Liu
Publikováno v:
Atherosclerosis. 357:41-50
Inflammation and reactive oxygen species (ROS) are important to the pathogenesis of atherosclerosis. The effect of antioxidants on atherosclerosis is inconsistent, and sometimes controversial. We aimed to test the hypothesis that attenuation of ather
Autor:
Sana M. Al-Khatib, Daniel M. Wojdyla, Christopher B. Granger, Lars Wallentin, David A. Garcia, Ziad Hijazi, Claes Held, John H. Alexander, Dragos Vinereanu, Gregory C. Flaker, Elaine M. Hylek, Renato D. Lopes
Publikováno v:
Circulation. 146:958-960
Autor:
Duan-Fang Liao, Yuqi Cui, Da Liu, Li Rong, Yixi Li, Xiaoming Liu, Jing-Shu Chi, Hui Wang, Hong Hao, Xiujuan Xia, Tingzi Hu, Huan Li, Yinjie Guo, Canxia Xu, Xue Zhang, Linfang Zhang, Gregory C. Flaker, Zhenguo Liu, Xi-Long Zheng, Jin Cai
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Epidemiological studies have suggested an association between Helicobacter pylori ( H pylori ) infection and atherosclerosis through undefined mechanisms. Endothelial dysfunction is critical to the development of atherosclerosis and relate
Autor:
Freek W.A. Verheugt, Christopher B. Granger, P. Oliveira Guimaraes, L. Thomas, Lars Wallentin, Renato D. Lopes, Bernard J. Gersh, Michael G. Hanna, John H. Alexander, Dragos Vinereanu, Elaine M. Hylek, David A. Garcia, Anne S. Hellkamp, Gregory C. Flaker
Publikováno v:
European Heart Journal. 38
Autor:
Tawseef Dar, Sharan Sharma, Sandeep Gautam, Vivek Y. Reddy, Gregory C Flaker, Greg C. Flaker, Zhenguo Liu, Bharath Yarlagadda, Paul G. Friedman, Andrea Natale, Dhanunjaya Lakkireddy, Muhammad R. Afzal, Rakesh Gopinathannair
Publikováno v:
Journal of the American College of Cardiology. 73:535
LP extractions is a relatively new field with limited operator experience. We compared the Nanostim (NS) vs Micra transcatheter (MT) LP. Pertinent details of retrieval such as indication, days post implantation, complications and post procedure devic
Autor:
John W. Eikelboom, Salim Yusuf, Maria Grazia Franzosi, Gregory C. Flaker, Janice Pogue, Patrick J. Commerford, Stuart J. Connolly, Jeff S. Healey
Publikováno v:
Circulation. 118:2029-2037
Background— Oral anticoagulation (OAC) therapy is effective in atrial fibrillation but requires vigilance to maintain the international normalized ratio in the therapeutic range. This report examines how differences in time in therapeutic range (TT
Autor:
Benjamin A. Steinberg, Alexandria J. M. Braganza, Christopher P. Cannon, Gemma Eminowicz, Sabina A. Murphy, Peter M. DiBattiste, Gregory C. Flaker
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 4:169-173
BACKGROUND Although clinical trials in the 1990s have found significant reductions in cardiovascular events with fixed doses of statins, specifically 40 mg of simvastatin or pravastatin, in clinical practice, treatment is usually initiated at lower d